AGTR1 and metabolic syndrome: RAS dysregulation mediates many of the changes in MetS and myocardial infarction (MI) and there is a link between the Ang II/AT1 signaling pathway and alterations in cardiac energy metabolism, cardiac insulin resistance, and the development of heart failure.